Campaign Strategy Clinton Obama Edwards Thompson Giuliani Romney McCain Ron Paul Richardson Election Process Debate Coverage Energy Iraq Mike Gravel Healthcare Huckabee Kucinich Poll Leaders Site Information Donations Chris Dodd Biden Fundraising Advertising Issues Mortgage Issue Defense Primary Oil Security Bloomberg Ethanol Petroleum Trade Policy Education Endorsements The Fed Tax Policy Afghanistan Monetary Policy Games Drugs China Gingrich Technology Foreign Policy Straw Poll Finance Reform The First Year Nunn Tobacco Epic Stem Cell Research Chemicals Polls Hagel Immigration Gore Brownback Gilmore Pakistan Construction Contributions
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Feb | ||||||
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | 31 | |||||
The Motley Fool analyzes the Clinton’s dissolved blind trust (done when Hillary entered the Presidential race.)
Sold were Anadarko Petroleum (APC), ExxonMobil (XOM), Dow Chemical (DOW), Dupont (DD), Pfizer (PFE), and Eli Lilly (LLY)
Did this move the market? It’s been a month. You be the judge.
Posted: July 16th, 2007 under Clinton, Petroleum, Chemicals, Drugs.
Comments: none